Compounded tirzepatide formulation challenges — looking for input

Dr.EndoIndy said:

The bulks-list asymmetry was the piece I had missed entirely.

Worth saying that the confident version of this is more useful to the person writing it than to the person reading it.

Ask again with the specifics and you will get a better answer than this one.

Dr.EndoIndy said:

The bulks-list asymmetry was the piece I had missed entirely.

No disagreement, though the timescale matters more than the mechanism here. Most of what looks like a difference in kind turns out to be a difference in how long somebody waited.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

Dr.EndoIndy said:

The bulks-list asymmetry was the piece I had missed entirely.

Thank you — that is the clearest version of this I have read, and I have read a lot of them.

From the other side of the consultation, briefly. It helps to ask what evidence would change your mind before you look at any. If nothing would, the discussion is not about evidence, and it is better to say so early than to spend nine posts discovering it.

I would rather be corrected than agreed with, if it comes to it.

paige_pharma said:

It helps to ask what evidence would change your mind before you look at any.

Can confirm. Same sequence, different timescale.